Loading the session
Loading the session
Loading instrument
$14.20
+0.00%Delayed · Pre-marketDelayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 16:00 IST · A quote does not mean the product is available to trade on your account.
Opens 8:00 pm IST
Opens 8:00 pm IST
Opens 8:00 pm IST
In brief
Questions investors ask
Quotes run fifteen minutes behind.
The 4 Nov 2026 close of $14.20 was 0.8% below its 50-day average ($14.31) and 0.9% below its 200-day average ($14.33). It has closed below the 200-day for 31 sessions, since 23 Sep 2026. The 50-day average crossed below the 200-day on 4 Nov 2026, in the latest session.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
1 month: +1.5% (SPY −1.6%). 3 months: −6.6% (SPY −0.4%). 1 year: −2.9% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: INMD, SPY · as of 4 Nov 2026
Closed at $14.20 on 4 Nov 2026: 14.8% below the 52-week high of $16.67 (2 Feb 2026) and 11.6% above the low of $12.72 (12 Mar 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
4 Nov 2026 volume of 807.2K shares was 1.7× the average of the 30 sessions before it (483.1K), as the price rose 0.9%. SPY traded 1.5× its own average that session.
Daily volume against a 30-session baseline · as of 4 Nov 2026
2.2M shares were sold short at the 15 Oct 2026 settlement, 3.9% of the 57.5M shares outstanding; covering them would take 4.8 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Price return, split-adjusted
At the 4 Nov 2026 close
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.
November 2, 2023
+14.35%October 12, 2023
−19.97%July 12, 2022
+15.51%